Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
PLoS One
; 16(3): e0248129, 2021.
Article
in En
| MEDLINE
| ID: mdl-33735185
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cellulitis
/
Skin Diseases, Bacterial
/
Abscess
/
Lipoglycopeptides
/
Anti-Bacterial Agents
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: